Governmental agencies made several new announcements this week that could impact how brands and suppliers approach food safety.
The FDA issued new draft guidance last week for allulose, stating it intends to allow manufacturers to exclude the low-calorie sweetener from total and added sugars on Nutrition Facts labels, marking the first time a sweetener will be exempt from the total or added sugars list.
Brands’ — such as Puffworks — efforts to prevent peanut allergies have inspired other brands to develop products that offer the early introduction of other allergens.
The FDA today announced it has issued a request for information (RFI) in the Federal Register to solicit comments and feedback from the public to gain more insight into how consumers use plant-based alternatives and how they understand terms like “milk” or “cheese” when used to label plant-based products.
In California, a revised FAW issued by the state Department of Public Health effectively prohibits the sale of hemp-derived CBD products, while the debate over defining an identity for the plant-based dairy category moves forward.
The Food and Drug Administration (FDA) announced today that it has expanded its list of approved dietary fibers that can be listed on the updated Nutrition Facts panel.
Food and Drug Administration (FDA) scientists have detected glyphosate, a chemical in a weed killer linked to cancer, in an array of commonly consumed U.S. based food products, according to emails obtained through a Freedom of Information Act request.
The FDA recently provided more context about how brands using natural sweeteners like honey or maple syrup should handle the labeling of their sugar content on the new Nutrition Facts label. But the question is, does this guidance provide enough clarity to sweeten industry leaders on this added sugar callout?
To make sense of the FDA’s recent flood of guidances and announcements, we spoke with a few industry experts to help us break down the regulatory and political jargon and explain what it could potentially mean for business leaders.
The U.S. Food and Drug Administration (FDA) announced last week that it will not actively enforce certain areas of the Food Safety Modernization Act (FSMA). One provision in particular has the potential to impact CPG supply chains.